ETGLX vs. ETIHX
Compare and contrast key facts about Eventide Gilead Fund (ETGLX) and Eventide Healthcare & Life Sciences Fund (ETIHX).
ETGLX is managed by Eventide Funds. It was launched on Jul 8, 2008. ETIHX is managed by Eventide Funds. It was launched on Dec 26, 2012.
Performance
ETGLX vs. ETIHX - Performance Comparison
Loading graphics...
ETGLX vs. ETIHX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ETGLX Eventide Gilead Fund | -10.60% | 23.50% | -0.23% | 22.52% | -34.17% | 11.22% | 55.13% | 33.84% | -2.56% | 32.85% |
ETIHX Eventide Healthcare & Life Sciences Fund | -10.26% | 56.73% | -10.13% | 11.01% | -19.62% | -16.87% | 37.12% | 58.74% | -0.27% | 45.83% |
Returns By Period
The year-to-date returns for both investments are quite close, with ETGLX having a -10.60% return and ETIHX slightly higher at -10.26%. Over the past 10 years, ETGLX has underperformed ETIHX with an annualized return of 11.23%, while ETIHX has yielded a comparatively higher 12.27% annualized return.
ETGLX
- 1D
- -1.09%
- 1M
- -10.45%
- YTD
- -10.60%
- 6M
- -6.16%
- 1Y
- 20.07%
- 3Y*
- 7.50%
- 5Y*
- -0.18%
- 10Y*
- 11.23%
ETIHX
- 1D
- -0.36%
- 1M
- -9.13%
- YTD
- -10.26%
- 6M
- 12.94%
- 1Y
- 51.24%
- 3Y*
- 12.55%
- 5Y*
- 0.28%
- 10Y*
- 12.27%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
ETGLX vs. ETIHX - Expense Ratio Comparison
ETGLX has a 1.31% expense ratio, which is higher than ETIHX's 1.30% expense ratio.
Return for Risk
ETGLX vs. ETIHX — Risk / Return Rank
ETGLX
ETIHX
ETGLX vs. ETIHX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Eventide Gilead Fund (ETGLX) and Eventide Healthcare & Life Sciences Fund (ETIHX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ETGLX | ETIHX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.87 | 1.82 | -0.95 |
Sortino ratioReturn per unit of downside risk | 1.33 | 2.46 | -1.13 |
Omega ratioGain probability vs. loss probability | 1.18 | 1.31 | -0.13 |
Calmar ratioReturn relative to maximum drawdown | 1.14 | 2.81 | -1.66 |
Martin ratioReturn relative to average drawdown | 4.59 | 10.69 | -6.10 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| ETGLX | ETIHX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.87 | 1.82 | -0.95 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.01 | 0.01 | -0.02 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.48 | 0.43 | +0.05 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.48 | 0.50 | -0.02 |
Correlation
The correlation between ETGLX and ETIHX is 0.78, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
ETGLX vs. ETIHX - Dividend Comparison
ETGLX's dividend yield for the trailing twelve months is around 14.08%, while ETIHX has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ETGLX Eventide Gilead Fund | 14.08% | 12.58% | 1.29% | 0.00% | 5.53% | 6.47% | 0.81% | 3.21% | 5.41% | 0.00% | 0.00% | 1.14% |
ETIHX Eventide Healthcare & Life Sciences Fund | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 10.78% | 3.49% | 2.08% | 7.33% | 1.28% | 0.00% | 1.22% |
Drawdowns
ETGLX vs. ETIHX - Drawdown Comparison
The maximum ETGLX drawdown since its inception was -41.41%, smaller than the maximum ETIHX drawdown of -55.11%. Use the drawdown chart below to compare losses from any high point for ETGLX and ETIHX.
Loading graphics...
Drawdown Indicators
| ETGLX | ETIHX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -41.41% | -55.11% | +13.70% |
Max Drawdown (1Y)Largest decline over 1 year | -14.44% | -12.50% | -1.94% |
Max Drawdown (5Y)Largest decline over 5 years | -41.41% | -49.49% | +8.08% |
Max Drawdown (10Y)Largest decline over 10 years | -41.41% | -55.11% | +13.70% |
Current DrawdownCurrent decline from peak | -17.68% | -12.50% | -5.18% |
Average DrawdownAverage peak-to-trough decline | -11.67% | -18.17% | +6.50% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.60% | 4.13% | -0.53% |
Volatility
ETGLX vs. ETIHX - Volatility Comparison
The current volatility for Eventide Gilead Fund (ETGLX) is 6.89%, while Eventide Healthcare & Life Sciences Fund (ETIHX) has a volatility of 7.75%. This indicates that ETGLX experiences smaller price fluctuations and is considered to be less risky than ETIHX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| ETGLX | ETIHX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.89% | 7.75% | -0.86% |
Volatility (6M)Calculated over the trailing 6-month period | 13.40% | 16.34% | -2.94% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.17% | 25.72% | -3.55% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.25% | 27.76% | -3.51% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.37% | 28.41% | -5.04% |